microdosing on tirzepatide for Peri Weight: Help? Instructions for Microdosing Compounded Tirzepatide+

Keep a simple pain and medication log during your first weeks on semaglutide to identify patterns and communicate them to your care team

Moss Compounding Pharmacy exists to help promote health and wellness for our human and veterinary patients through personalized medication solutions and expert clinical services

GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) are contraindicated during breastfeeding per UK Summary of Product Characteristics No weight loss injection currently has regulatory approval for use whilst breastfeeding in the UK Transfer into breast milk and effects on nursing infants remain unknown due to absence of human studies Appetite suppression from these medications may compromise maternal nutrition needed for adequate milk production Safe alternatives include gradual dietary modification, regular physical activity, and NHS weight management programmes Women should defer weight loss medications until breastfeeding is completed and seek GP advice for postpartum weight concerns Table of Contents Weight Loss Injections and Breastfeeding: Key Safety Considerations Types of Weight Loss Injections and Their Use During Lactation Potential Risks to Breastfed Infants Alternative Approaches to Postpartum Weight Management When to Seek Medical Advice About Weight Loss While Breastfeeding Frequently Asked Questions Weight Loss Injections and Breastfeeding: Key Safety Considerations Weight loss injections, particularly GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda), have become increasingly popular for weight management

Youre already taking the highest dose of Wegovy , or your doctor has increased your dose, but your weight has not changed

Semaglutide mimics GLP-1 to target brain areas responsible for hunger control and food intake regulation